Global and United States Chloroquine Phosphate Market Report & Forecast 2022-2028

Chloroquine phosphate (also known as chloroquine) is an antimalarial medicine approved in the United States for either prevention or treatment of certain types of malaria and for treatment of extraintestinal parasites. Certain types of malaria, resistant strains, and complicated cases typically require different or additional medication. Chloroquine is also occasionally used for amebiasis that is occurring outside the intestines, rheumatoid arthritis, and lupus erythematosus. While it has not been formally studied in pregnancy, it appears safe. It is also being studied to treat COVID-19 as of 2020.
Market Analysis and Insights: Global and United States Chloroquine Phosphate Market
This report focuses on global and United States Chloroquine Phosphate market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Chloroquine Phosphate market size is estimated to be worth US$ 119.2 million in 2022 and is forecast to a readjusted size of US$ 58 million by 2028 with a CAGR of -11.4% during the review period. Fully considering the economic change by this health crisis, by Type, Chloroquine Phosphate Injectable accounting for % of the Chloroquine Phosphate global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Malaria was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
Middle East and Africa is the dominant market in the global Chloroquine Phosphate market in terms of value. Sanofi and Bayer are the two players with the largest sales share, occupying 9.24% and 8.36% of the market share in 2019, respectively. And It is worth of noticing that chloroquine phosphate used in COVID-2019 will occupy 24.58% of the market share in 2020.
Global Chloroquine Phosphate Scope and Market Size
Chloroquine Phosphate market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Chloroquine Phosphate market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Chloroquine Phosphate market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Chloroquine Phosphate Injectable
Chloroquine Phosphate Oral
Segment by Application
Malaria
COVID-19
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Sanofi
Bayer
Ipca Laboratories
Cipla
Teva Pharmaceuticals
Merck
AstraZeneca
Pharco Pharmaceuticals
Indofarma
Jayson Pharmaceuticals
AM-Europharma
Humax Pharmaceutical
Atlantic Pharmaceutical
Ace Pharmaceuticals BV